Liquidia (LQDA)
Commercializes inhaled treprostinil therapies for pulmonary hypertension and develops twice-daily L606.
$69.13
After hours+0.49 (+0.71%)
At close$68.64(+3.33%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 81.79% | 73.21M shares | |
|---|---|---|---|
| 366 holders · as of Jun 30, 2026 | |||
| Insiders | 5.92% | 5.30M shares | |
| 17 holders · as of Sep 15, 2026 | |||
| Other | 12.29% | 11.00M shares | |
| remainder | |||
89.51M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
366 holders · 73.21M shares · 130 new positions · 237 increased · 84 reduced · 37 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.79M | 12.05% | +5.30M | Aug 7, 2026 |
| Farallon Capital Management LLC | 8.37M | 9.35% | −291.0K | Aug 14, 2026 |
| Caligan Partners LP | 8.12M | 9.07% | 0 | Aug 14, 2026 |
| Findell Capital Management LLC | 3.50M | 3.91% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 3.14M | 3.51% | +212.2K | Aug 13, 2026 |
| State Street Corp | 3.03M | 3.39% | +1.15M | Aug 7, 2026 |
| Opaleye Management Inc. | 2.45M | 2.73% | −97.5K | Aug 14, 2026 |
| Geode Capital Management, LLC | 2.12M | 2.37% | +192.3K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.00% | 4.21M | Nov 8, 2024 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 14, 2026 | Raman Singhdirector | Sale | 8,468 | $66.16 | 44,637 |
| Sep 11, 2026 | Raman Singhdirector | Sale | 9,024 | $68.62 | 44,637 |
| Sep 1, 2026 | Sarah Kreppofficer: Chief Human Resource Officer | Sale | 274 | $67.76 | 117,308 |
| Aug 21, 2026 | Jason Adairofficer: Chief Business Officer | Sale · 2 lots | 73,631 | $69.09 | 174,606 |
| Aug 20, 2026 | Katherine Rielly-Gauvindirector | Sale | 18,393 | $72.23 | 44,637 |
| Aug 19, 2026 | Katherine Rielly-Gauvindirector | Sale | 36,789 | $74.99 | 44,637 |
| Aug 19, 2026 | Rajeev Saggarofficer: Chief Medical Officer | Sale | 50,000 | $74.06 | 142,265 |
| Aug 17, 2026 | Rajeev Saggarofficer: Chief Medical Officer | Sale | 29,534 | $76.84 | 142,265 |
| Jul 27, 2026 | Jason Adairofficer: Chief Business Officer | Sale | 688 | $87.53 | 216,438 |
| Jul 27, 2026 | Dana Boyleofficer: Chief Accounting Officer | Sale | 1,600 | $87.53 | 167,919 |
House and Senate disclosures
Not reported.